KMDA
NASDAQ · Biotechnology
Kamada Ltd
$7.11
-0.08 (-1.11%)
Open$7.00
Previous Close$7.19
Day High$7.19
Day Low$6.98
52W High$9.35
52W Low$6.50
Volume—
Avg Volume37.1K
Market Cap421.69M
P/E Ratio20.70
EPS$0.35
SectorBiotechnology
Analyst Ratings
Strong Buy
9 analysts
Price Target
+308.2% upside
Current
$7.11
$7.11
Target
$29.02
$29.02
$25.25
$29.02 avg
$47.24
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 154.01M | 153.15M | 67.17M |
| Net Income | 20.08M | 17.97M | -1,989,318 |
| Profit Margin | 5.8% | 5.5% | -3.0% |
| EBITDA | 28.11M | 26.56M | -2,803,887 |
| Free Cash Flow | — | — | -2,727,774 |
| Rev Growth | +0.6% | +0.6% | +14.3% |
| Debt/Equity | 0.04 | 0.04 | 0.09 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.76 | +2.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.01 | +0.66% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.05 | +0.14% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $468.42 | +0.35% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.03 | +0.90% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $288.18 | +0.62% | 64.3 | 37.13B |